FDA Recalls Oseltamivir Phosphate Oral Suspension for Out-of-Specification Impurities
Amneal Pharmaceuticals is recalling 46,037 bottles of Oseltamivir Phosphate Oral Suspension due to failed quality test results showing impurities and degradation. The FDA classified this as a Class II recall affecting nationwide distribution.
- Product
- OSELTAMIVIR PHOSPHATE — OSELTAMIVIR PHOSPHATE (OSELTAMIVIR PHOSPHATE)
- Category
- Drug
- Distribution
- Distributed nationwide